CN Patent

CN113332267A — 苯丁酸钠在制备预防或治疗帕金森病的药物中的应用

Assigned to Sun Yat Sen Memorial Hospital Sun Yat Sen University · Expires 2021-09-03 · 5y expired

What this patent protects

本发明涉及生物制药领域，尤其涉及苯丁酸钠(Sodium phenylbutyrate，SP)在制备预防或治疗帕金森病的药物中的应用。本发明通过整合多组学数据进行基因共表达网络的探索，得到可以明显逆转模块中异常表达基因的药物SP。动物实验表明，该药物可改善动物的行为，防止帕金森病的发展。因此SP具有预防帕金森病发展的作用以及提高帕金森病治疗的效果。

USPTO Abstract

本发明涉及生物制药领域，尤其涉及苯丁酸钠(Sodium phenylbutyrate，SP)在制备预防或治疗帕金森病的药物中的应用。本发明通过整合多组学数据进行基因共表达网络的探索，得到可以明显逆转模块中异常表达基因的药物SP。动物实验表明，该药物可改善动物的行为，防止帕金森病的发展。因此SP具有预防帕金森病发展的作用以及提高帕金森病治疗的效果。

Drugs covered by this patent

Patent Metadata

Patent number
CN113332267A
Jurisdiction
CN
Classification
—
Expires
2021-09-03
Drug substance claim
No
Drug product claim
No
Assignee
Sun Yat Sen Memorial Hospital Sun Yat Sen University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.